Damps T et al. |
The effect of wool hydrolysates on squamous cell carcinoma cells in vitro. Possible implications for cancer treatment. |
2017 |
PLoS ONE |
pmid:28859143
|
Asche CV et al. |
Evaluation of Resource Utilization and Treatment Patterns in Patients with Actinic Keratosis in the United States. |
2016 Mar-Apr |
Value Health |
pmid:27021759
|
Zane C et al. |
A Randomized Split-Face Clinical Trial of Photodynamic Therapy with Methyl Aminolevulinate versus Ingenol Mebutate Gel for the Treatment of Multiple Actinic Keratoses of the Face and Scalp. |
2016 |
Dermatology (Basel) |
pmid:27578305
|
Mühlstädt M |
Ingenol Mebutate vs. Daylight Photodynamic Therapy in a Kidney Transplant Recipient. |
2016 |
Dermatology (Basel) |
pmid:27513345
|
Erlendsson AM et al. |
Repeated Treatments with Ingenol Mebutate Prevents Progression of UV-Induced Photodamage in Hairless Mice. |
2016 |
PLoS ONE |
pmid:27636884
|
Emmert S et al. |
Tumor-Preferential Induction of Immune Responses and Epidermal Cell Death in Actinic Keratoses by Ingenol Mebutate. |
2016 |
PLoS ONE |
pmid:27612149
|
Liu M et al. |
Synthesis and Cytotoxicity against K562 Cells of 3-O-Angeloyl-20-O-acetyl Ingenol, a Derivative of Ingenol Mebutate. |
2016 |
Int J Mol Sci |
pmid:27548156
|
Mohanna MT and Hofbauer GF |
Bowenoid Actinic Keratosis and Bowen's Disease Treated Successfully with Ingenol Mebutate. |
2016 |
Dermatology (Basel) |
pmid:27513957
|
Mainetti C et al. |
Successful Treatment of Relapsing Bowen's Disease with Ingenol Mebutate: The Use of Dermoscopy to Monitor the Therapeutic Response. |
2016 |
Dermatology (Basel) |
pmid:27513936
|
Gaide O et al. |
Ingenol Mebutate 500 μg for Treatment of the Scalp in Refractory Field Cancerization. |
2016 |
Dermatology (Basel) |
pmid:27513862
|
Gaide O and Cattin V |
Ingenol Mebutate 500 µg on the Cheekbones with Concomitant Conjunctivitis. |
2016 |
Dermatology (Basel) |
pmid:27513756
|
Tzika E et al. |
Ingenol Mebutate for Recalcitrant Chronic Actinic Cheilitis. |
2016 |
Dermatology (Basel) |
pmid:27513668
|
Stieger M and Hunger RE |
Ingenol Mebutate Treatment in a Patient with Gorlin Syndrome. |
2016 |
Dermatology (Basel) |
pmid:27513585
|
Gadaldi K et al. |
Ingenol Mebutate for Lentigo Maligna: A Case Report. |
2016 |
Dermatology (Basel) |
pmid:27513527
|
Alkhalaf A and Hofbauer GF |
Ingenol Mebutate 150 mg as Physician-Directed Treatment of Bowen's Disease Under Occlusion. |
2016 |
Dermatology (Basel) |
pmid:27512986
|
Le TT et al. |
IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate. |
2016 |
PLoS ONE |
pmid:27100888
|
Stockfleth E et al. |
New Topical Treatment Options for Actinic Keratosis: A Systematic Review. |
2016 |
Acta Derm. Venereol. |
pmid:26068001
|
Bhandari PR and Pai VV |
Could ingenol mebutate be useful in managing nonmelanoma skin cancers? |
2015 Apr-Jun |
Indian J Cancer |
pmid:26853424
|
De Felice B et al. |
Ingenol mebutate treatment in keloids. |
2015 |
BMC Res Notes |
pmid:26391582
|
Pellacani G et al. |
A randomized trial comparing simultaneous vs. sequential field treatment of actinic keratosis with ingenol mebutate on two separate areas of the head and body. |
2015 |
J Eur Acad Dermatol Venereol |
pmid:26300464
|